The last few years have seen tremendous growth in the global pharmaceutical market, ending last year at a valuation of $1.25 trillion.The industry was valued at $390 billion in 2001. While companies have thrived in the booming market, how much does a scientist make?In this article, we will...
Brand equity is a measure of the perceived worth of a brand or product in the eyes of consumers. Learn how to build and strengthen your brand’s equity.
The highest-paid CEO in the medical device industry is not at the largest company. Abbott CEO Robert Ford topped the list, earning $21.7 million in compensation in 2022. However, Abbott makes more than medical devices – it has nutritional, diagnostic, medical device and pharmaceutical divisions....
Energy companies are battling public concern over climate change. Tech companies are judged on whether big data and social media positively contribute to society. Pharmaceutical companies face growing calls to justify their use of patents, and to make lifesaving medications more affordable ...
Pharmaceutical companies use intellectual property rights to extract vast wealth from the healthcare market—including from the US government which is disallowed from bargaining with drug makers when it comes to Medicare and Medicaid plans. Though changing that rule is getting support from both sides ...
these knowledge principles from the R&D team in China were vital to solving a similar problem faced by many pharmaceutical companies in Switzerland and globally; these companies needed to more effectively and efficiently determine the moisture content of a drug capsule to determine whether it met indu...
they had all kinds of warning labels on the bottles. Which we were selling them for children sports gear and so I was really disappointed. Some very popular pharmaceutical companies that sell all these chemicals. So between that and them not actually working for a very long time, I was like...
Do you think it’s moral for pharmaceutical companies to charge so much for medications? Do you think it’s okay to use animals for research? If you had a limited supply of drugs, how do you decide which patients will get them?
It’s also, fundamentally, not good for shareholders. The NYSE ARCA Pharmaceutical Index has delivered a total return of 5.2% annually over the past five years, compared with 10% for the S&P 500.“Without access to talent, without access to technologies, big pharma companies are just pouring...
‘living drug’, identifying and killing cancer cells. the field for car-t is currently booming, with over 800 clinical trials running. however, a potential weak spot for pharmaceutical companies may be emerging due to significant challenges, including: a completely different unit of sale (i.e....